Our R&D portfolio for paediatric HIV
What we have achieved
Our research is helping countries replace older, difficult–to–use, and sometimes ineffective formulations and scale up new, optimum treatments for young children.
What we are doing for children living with HIV
In order to help end the neglect of babies and young children with HIV, we have developed an easy-to-administer, strawberry-flavoured ‘4-in-1’ treatment called Quadrimune, together with the Indian company Cipla. But our engagement goes well beyond drug development alone. Through a series of partnerships, we are working to ensure improved treatments for kids are rolled out where they are needed most.
Get our latest news, personal stories, research articles, and job opportunities.